General Information of Drug Transporter (DT)
DT ID DTD0305 Transporter Info
Gene Name SLC35E4
Transporter Name Solute carrier family 35 member E4
Gene ID
339665
UniProt ID
Q6ICL7
Post-Translational Modification of This DT
Overview of SLC35E4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35E4 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

225

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35E4 Serine 225 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC35E4 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

228

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35E4 Serine 228 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC35E4 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

252

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35E4 Serine 252 has the potential to affect its expression or activity.

  Threonine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35E4 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

219

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35E4 Threonine 219 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC35E4 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

224

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35E4 Threonine 224 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC35E4 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

248

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35E4 Threonine 248 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35E4 [1]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

222

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35E4 Tyrosine 222 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35E4 [2]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

202

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC35E4 Lysine 202 has the potential to affect its expression or activity.
References
1 Characterization of native protein complexes and protein isoform variation using size-fractionation-based quantitative proteomics. Mol Cell Proteomics. 2013 Dec;12(12):3851-73.
2 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.